Titre : Vaccins antiviraux

Vaccins antiviraux : Questions médicales fréquentes

Nom anglais: Viral Vaccines

Descriptor UI: D014765

Tree Number: D20.215.894.899

Termes MeSH sélectionnés :

Quality Improvement

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une infection virale ?

Le diagnostic repose sur des tests virologiques, des analyses sanguines et des symptômes cliniques.
Infections virales Tests diagnostiques
#2

Quels tests sont utilisés pour les vaccins antiviraux ?

Des tests sérologiques et des cultures virales sont souvent utilisés pour évaluer l'immunité.
Vaccins antiviraux Tests sérologiques
#3

Les symptômes indiquent-ils un besoin de vaccin ?

Des symptômes comme la fièvre ou la fatigue peuvent indiquer une infection nécessitant un vaccin.
Symptômes Vaccins antiviraux
#4

Comment évaluer l'efficacité d'un vaccin ?

L'efficacité est évaluée par des études cliniques et des taux d'infection dans la population vaccinée.
Efficacité des vaccins Études cliniques
#5

Les tests de dépistage sont-ils nécessaires avant vaccination ?

Des tests peuvent être recommandés pour certaines populations à risque avant la vaccination.
Dépistage Vaccination

Symptômes 5

#1

Quels symptômes nécessitent un vaccin antiviral ?

Des symptômes comme la toux, la fièvre ou des douleurs musculaires peuvent indiquer un besoin.
Symptômes Vaccins antiviraux
#2

Les effets secondaires des vaccins sont-ils fréquents ?

Les effets secondaires comme la douleur au site d'injection sont courants mais généralement légers.
Effets secondaires Vaccins antiviraux
#3

Comment distinguer une infection d'un effet secondaire ?

Les infections présentent des symptômes persistants, tandis que les effets secondaires sont temporaires.
Infections virales Effets secondaires
#4

Les symptômes varient-ils selon le type de vaccin ?

Oui, les symptômes peuvent varier selon le type de vaccin et la réponse immunitaire individuelle.
Types de vaccins Réponse immunitaire
#5

Les symptômes d'une infection virale sont-ils similaires ?

Oui, de nombreuses infections virales partagent des symptômes comme la fièvre et la fatigue.
Infections virales Symptômes

Prévention 5

#1

Comment les vaccins antiviraux préviennent-ils les infections ?

Ils stimulent le système immunitaire à reconnaître et combattre les virus spécifiques.
Prévention Vaccins antiviraux
#2

À quel âge doit-on commencer la vaccination antivirale ?

L'âge de vaccination dépend du vaccin, mais beaucoup commencent dès l'enfance.
Vaccination Enfance
#3

Les vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?

Certains vaccins sont sûrs pendant la grossesse, mais il est essentiel de consulter un médecin.
Vaccins antiviraux Grossesse
#4

Les vaccins protègent-ils contre toutes les souches virales ?

Non, les vaccins ciblent des souches spécifiques, et des mises à jour peuvent être nécessaires.
Souches virales Vaccins antiviraux
#5

Quelle est l'importance de la vaccination de masse ?

La vaccination de masse aide à atteindre l'immunité collective et à réduire la propagation des virus.
Vaccination de masse Immunité collective

Traitements 5

#1

Les vaccins antiviraux sont-ils des traitements ?

Non, les vaccins préviennent les infections, tandis que les traitements ciblent les infections existantes.
Vaccins antiviraux Traitements antiviraux
#2

Quels traitements sont disponibles après infection ?

Des antiviraux comme l'oseltamivir peuvent être prescrits pour traiter certaines infections virales.
Antiviraux Infections virales
#3

Les vaccins peuvent-ils réduire la gravité des symptômes ?

Oui, les vaccins peuvent atténuer la gravité des symptômes en cas d'infection post-vaccination.
Vaccins antiviraux Symptômes
#4

Les traitements sont-ils nécessaires après vaccination ?

Pas nécessairement, mais des traitements peuvent être requis si une infection survient malgré la vaccination.
Vaccination Traitements antiviraux
#5

Les vaccins antiviraux nécessitent-ils des traitements préventifs ?

Non, les vaccins sont une mesure préventive, mais des traitements peuvent être nécessaires en cas d'exposition.
Vaccins antiviraux Prévention

Complications 5

#1

Quelles complications peuvent survenir après vaccination ?

Des complications rares incluent des réactions allergiques sévères ou des syndromes neurologiques.
Complications Réactions allergiques
#2

Les complications sont-elles fréquentes ?

Non, la plupart des complications sont rares et les bénéfices de la vaccination l'emportent sur les risques.
Complications Vaccins antiviraux
#3

Comment gérer les complications post-vaccinales ?

Consulter un professionnel de santé pour évaluer et traiter les complications éventuelles.
Gestion des complications Vaccins antiviraux
#4

Les complications varient-elles selon le vaccin ?

Oui, chaque vaccin peut avoir des profils de complications différents selon sa composition.
Profils de complications Vaccins antiviraux
#5

Les complications peuvent-elles affecter l'immunité ?

Certaines complications peuvent temporairement affecter la réponse immunitaire, mais cela est rare.
Immunité Complications

Facteurs de risque 5

#1

Quels sont les facteurs de risque pour les infections virales ?

Les facteurs incluent l'âge, les maladies chroniques, et l'immunodépression.
Facteurs de risque Infections virales
#2

Les antécédents médicaux influencent-ils la vaccination ?

Oui, des antécédents de réactions allergiques ou de maladies peuvent influencer le choix du vaccin.
Antécédents médicaux Vaccination
#3

Les voyages augmentent-ils le risque d'infection ?

Oui, voyager dans des zones à risque peut augmenter l'exposition à des virus spécifiques.
Voyages Infections virales
#4

Les personnes âgées ont-elles plus de risques ?

Oui, les personnes âgées sont plus susceptibles de développer des complications graves liées aux infections.
Personnes âgées Complications
#5

Le mode de vie influence-t-il le risque d'infection ?

Oui, un mode de vie sain, incluant une bonne nutrition et de l'exercice, peut réduire le risque.
Mode de vie Infections virales
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vaccins antiviraux : Questions médicales les plus fréquentes", "headline": "Vaccins antiviraux : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vaccins antiviraux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-24", "dateModified": "2025-02-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vaccins antiviraux" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vaccins", "url": "https://questionsmedicales.fr/mesh/D014612", "about": { "@type": "MedicalCondition", "name": "Vaccins", "code": { "@type": "MedicalCode", "code": "D014612", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccins anti-adénovirus", "alternateName": "Adenovirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D062705", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-adénovirus", "code": { "@type": "MedicalCode", "code": "D062705", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.024" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre le SIDA", "alternateName": "AIDS Vaccines", "url": "https://questionsmedicales.fr/mesh/D016915", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le SIDA", "code": { "@type": "MedicalCode", "code": "D016915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.050" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la COVID-19", "alternateName": "COVID-19 Vaccines", "url": "https://questionsmedicales.fr/mesh/D000086663", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la COVID-19", "code": { "@type": "MedicalCode", "code": "D000086663", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.085" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin ChAdOx1 nCoV-19", "alternateName": "ChAdOx1 nCoV-19", "url": "https://questionsmedicales.fr/mesh/D000090985", "about": { "@type": "MedicalCondition", "name": "Vaccin ChAdOx1 nCoV-19", "code": { "@type": "MedicalCode", "code": "D000090985", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.085.063" } } }, { "@type": "MedicalWebPage", "name": "Ad26COVS1", "alternateName": "Ad26COVS1", "url": "https://questionsmedicales.fr/mesh/D000090984", "about": { "@type": "MedicalCondition", "name": "Ad26COVS1", "code": { "@type": "MedicalCode", "code": "D000090984", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.085.125" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre le cytomégalovirus", "alternateName": "Cytomegalovirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022482", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le cytomégalovirus", "code": { "@type": "MedicalCode", "code": "D022482", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.120" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la dengue", "alternateName": "Dengue Vaccines", "url": "https://questionsmedicales.fr/mesh/D053059", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la dengue", "code": { "@type": "MedicalCode", "code": "D053059", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.162" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la maladie à virus Ebola", "alternateName": "Ebola Vaccines", "url": "https://questionsmedicales.fr/mesh/D046129", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la maladie à virus Ebola", "code": { "@type": "MedicalCode", "code": "D046129", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.205" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les herpèsvirus", "alternateName": "Herpesvirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022283", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les herpèsvirus", "code": { "@type": "MedicalCode", "code": "D022283", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin contre la varicelle", "alternateName": "Chickenpox Vaccine", "url": "https://questionsmedicales.fr/mesh/D019433", "about": { "@type": "MedicalCondition", "name": "Vaccin contre la varicelle", "code": { "@type": "MedicalCode", "code": "D019433", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.130" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin contre le zona", "alternateName": "Herpes Zoster Vaccine", "url": "https://questionsmedicales.fr/mesh/D053061", "about": { "@type": "MedicalCondition", "name": "Vaccin contre le zona", "code": { "@type": "MedicalCode", "code": "D053061", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.130.400" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccin contre le zona", "alternateName": "Herpes Zoster Vaccine", "url": "https://questionsmedicales.fr/mesh/D053061", "about": { "@type": "MedicalCondition", "name": "Vaccin contre le zona", "code": { "@type": "MedicalCode", "code": "D053061", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.130.400" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les virus herpès simplex", "alternateName": "Herpes Simplex Virus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022301", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les virus herpès simplex", "code": { "@type": "MedicalCode", "code": "D022301", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.400" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la maladie de Marek", "alternateName": "Marek Disease Vaccines", "url": "https://questionsmedicales.fr/mesh/D022501", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la maladie de Marek", "code": { "@type": "MedicalCode", "code": "D022501", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins antigrippaux", "alternateName": "Influenza Vaccines", "url": "https://questionsmedicales.fr/mesh/D007252", "about": { "@type": "MedicalCondition", "name": "Vaccins antigrippaux", "code": { "@type": "MedicalCode", "code": "D007252", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.302" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre l'encéphalite japonaise", "alternateName": "Japanese Encephalitis Vaccines", "url": "https://questionsmedicales.fr/mesh/D022321", "about": { "@type": "MedicalCondition", "name": "Vaccins contre l'encéphalite japonaise", "code": { "@type": "MedicalCode", "code": "D022321", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.320" } } }, { "@type": "MedicalWebPage", "name": "Vaccin contre la rougeole", "alternateName": "Measles Vaccine", "url": "https://questionsmedicales.fr/mesh/D008458", "about": { "@type": "MedicalCondition", "name": "Vaccin contre la rougeole", "code": { "@type": "MedicalCode", "code": "D008458", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.404" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antiourlien", "alternateName": "Mumps Vaccine", "url": "https://questionsmedicales.fr/mesh/D009108", "about": { "@type": "MedicalCondition", "name": "Vaccin antiourlien", "code": { "@type": "MedicalCode", "code": "D009108", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.488" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les papillomavirus", "alternateName": "Papillomavirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D053918", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les papillomavirus", "code": { "@type": "MedicalCode", "code": "D053918", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.498" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18", "alternateName": "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18", "url": "https://questionsmedicales.fr/mesh/D000068857", "about": { "@type": "MedicalCondition", "name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18", "code": { "@type": "MedicalCode", "code": "D000068857", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.498.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre les virus para-influenza", "alternateName": "Parainfluenza Vaccines", "url": "https://questionsmedicales.fr/mesh/D022241", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les virus para-influenza", "code": { "@type": "MedicalCode", "code": "D022241", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.500" } } }, { "@type": "MedicalWebPage", "name": "Vaccins antipoliomyélitiques", "alternateName": "Poliovirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D023321", "about": { "@type": "MedicalCondition", "name": "Vaccins antipoliomyélitiques", "code": { "@type": "MedicalCode", "code": "D023321", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.623" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin antipoliomyélitique inactivé", "alternateName": "Poliovirus Vaccine, Inactivated", "url": "https://questionsmedicales.fr/mesh/D011054", "about": { "@type": "MedicalCondition", "name": "Vaccin antipoliomyélitique inactivé", "code": { "@type": "MedicalCode", "code": "D011054", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.623.500" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antipoliomyélitique oral", "alternateName": "Poliovirus Vaccine, Oral", "url": "https://questionsmedicales.fr/mesh/D011055", "about": { "@type": "MedicalCondition", "name": "Vaccin antipoliomyélitique oral", "code": { "@type": "MedicalCode", "code": "D011055", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.623.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre la maladie d'Aujeszky", "alternateName": "Pseudorabies Vaccines", "url": "https://questionsmedicales.fr/mesh/D022421", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la maladie d'Aujeszky", "code": { "@type": "MedicalCode", "code": "D022421", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.632" } } }, { "@type": "MedicalWebPage", "name": "Vaccins antirabiques", "alternateName": "Rabies Vaccines", "url": "https://questionsmedicales.fr/mesh/D011819", "about": { "@type": "MedicalCondition", "name": "Vaccins antirabiques", "code": { "@type": "MedicalCode", "code": "D011819", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.700" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les virus respiratoires syncytiaux", "alternateName": "Respiratory Syncytial Virus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022261", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les virus respiratoires syncytiaux", "code": { "@type": "MedicalCode", "code": "D022261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.730" } } }, { "@type": "MedicalWebPage", "name": "Vaccins anti-rotavirus", "alternateName": "Rotavirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022243", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-rotavirus", "code": { "@type": "MedicalCode", "code": "D022243", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.760" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antirubéoleux", "alternateName": "Rubella Vaccine", "url": "https://questionsmedicales.fr/mesh/D012411", "about": { "@type": "MedicalCondition", "name": "Vaccin antirubéoleux", "code": { "@type": "MedicalCode", "code": "D012411", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.779" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin contre la rougeole, les oreillons et la rubéole", "alternateName": "Measles-Mumps-Rubella Vaccine", "url": "https://questionsmedicales.fr/mesh/D022542", "about": { "@type": "MedicalCondition", "name": "Vaccin contre la rougeole, les oreillons et la rubéole", "code": { "@type": "MedicalCode", "code": "D022542", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.779.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre le SIDA simien", "alternateName": "SAIDS Vaccines", "url": "https://questionsmedicales.fr/mesh/D018449", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le SIDA simien", "code": { "@type": "MedicalCode", "code": "D018449", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.790" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antivariolique", "alternateName": "Smallpox Vaccine", "url": "https://questionsmedicales.fr/mesh/D012900", "about": { "@type": "MedicalCondition", "name": "Vaccin antivariolique", "code": { "@type": "MedicalCode", "code": "D012900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.859" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les hépatites virales", "alternateName": "Viral Hepatitis Vaccines", "url": "https://questionsmedicales.fr/mesh/D014761", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les hépatites virales", "code": { "@type": "MedicalCode", "code": "D014761", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.955" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccins anti-hépatite A", "alternateName": "Hepatitis A Vaccines", "url": "https://questionsmedicales.fr/mesh/D022362", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-hépatite A", "code": { "@type": "MedicalCode", "code": "D022362", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.955.395" } } }, { "@type": "MedicalWebPage", "name": "Vaccins anti-hépatite B", "alternateName": "Hepatitis B Vaccines", "url": "https://questionsmedicales.fr/mesh/D017325", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-hépatite B", "code": { "@type": "MedicalCode", "code": "D017325", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.955.400" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre le virus du Nil occidental", "alternateName": "West Nile Virus Vaccines", "url": "https://questionsmedicales.fr/mesh/D053060", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le virus du Nil occidental", "code": { "@type": "MedicalCode", "code": "D053060", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.962" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antiamaril", "alternateName": "Yellow Fever Vaccine", "url": "https://questionsmedicales.fr/mesh/D022341", "about": { "@type": "MedicalCondition", "name": "Vaccin antiamaril", "code": { "@type": "MedicalCode", "code": "D022341", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.970" } } } ], "about": { "@type": "MedicalCondition", "name": "Vaccins antiviraux", "alternateName": "Viral Vaccines", "code": { "@type": "MedicalCode", "code": "D014765", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yukai Huang", "url": "https://questionsmedicales.fr/author/Yukai%20Huang", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Xiao Guo", "url": "https://questionsmedicales.fr/author/Xiao%20Guo", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Yuancheng Zhou", "url": "https://questionsmedicales.fr/author/Yuancheng%20Zhou", "affiliation": { "@type": "Organization", "name": "Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China." } }, { "@type": "Person", "name": "Dongying Liu", "url": "https://questionsmedicales.fr/author/Dongying%20Liu", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Jingrui Mao", "url": "https://questionsmedicales.fr/author/Jingrui%20Mao", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Measuring Equity for Quality Improvement.", "datePublished": "2023-03-21", "url": "https://questionsmedicales.fr/article/37201995", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clp.2023.01.010" } }, { "@type": "ScholarlyArticle", "name": "Resuscitation Quality Improvement (RQI", "datePublished": "2022-09-01", "url": "https://questionsmedicales.fr/article/36041201", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3928/00220124-20220805-03" } }, { "@type": "ScholarlyArticle", "name": "Using Quality Improvement to Improve Value and Reduce Waste.", "datePublished": "2023-03-27", "url": "https://questionsmedicales.fr/article/37201993", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clp.2023.01.009" } }, { "@type": "ScholarlyArticle", "name": "Mapping quality improvement education initiatives to Standards for QUality Improvement Reporting Excellence (SQUIRE) guidelines.", "datePublished": "2023-01-05", "url": "https://questionsmedicales.fr/article/36604856", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jocn.16610" } }, { "@type": "ScholarlyArticle", "name": "Integrating Implementation Science with Quality Improvement to Improve Perinatal Outcomes.", "datePublished": "2023-03-27", "url": "https://questionsmedicales.fr/article/37201985", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clp.2023.01.002" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Mélanges complexes", "item": "https://questionsmedicales.fr/mesh/D045424" }, { "@type": "ListItem", "position": 3, "name": "Produits biologiques", "item": "https://questionsmedicales.fr/mesh/D001688" }, { "@type": "ListItem", "position": 4, "name": "Vaccins", "item": "https://questionsmedicales.fr/mesh/D014612" }, { "@type": "ListItem", "position": 5, "name": "Vaccins antiviraux", "item": "https://questionsmedicales.fr/mesh/D014765" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vaccins antiviraux - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vaccins antiviraux", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vaccins antiviraux", "description": "Comment diagnostiquer une infection virale ?\nQuels tests sont utilisés pour les vaccins antiviraux ?\nLes symptômes indiquent-ils un besoin de vaccin ?\nComment évaluer l'efficacité d'un vaccin ?\nLes tests de dépistage sont-ils nécessaires avant vaccination ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Quality+Improvement#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vaccins antiviraux", "description": "Quels symptômes nécessitent un vaccin antiviral ?\nLes effets secondaires des vaccins sont-ils fréquents ?\nComment distinguer une infection d'un effet secondaire ?\nLes symptômes varient-ils selon le type de vaccin ?\nLes symptômes d'une infection virale sont-ils similaires ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Quality+Improvement#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vaccins antiviraux", "description": "Comment les vaccins antiviraux préviennent-ils les infections ?\nÀ quel âge doit-on commencer la vaccination antivirale ?\nLes vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?\nLes vaccins protègent-ils contre toutes les souches virales ?\nQuelle est l'importance de la vaccination de masse ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Quality+Improvement#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vaccins antiviraux", "description": "Les vaccins antiviraux sont-ils des traitements ?\nQuels traitements sont disponibles après infection ?\nLes vaccins peuvent-ils réduire la gravité des symptômes ?\nLes traitements sont-ils nécessaires après vaccination ?\nLes vaccins antiviraux nécessitent-ils des traitements préventifs ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Quality+Improvement#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vaccins antiviraux", "description": "Quelles complications peuvent survenir après vaccination ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications post-vaccinales ?\nLes complications varient-elles selon le vaccin ?\nLes complications peuvent-elles affecter l'immunité ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Quality+Improvement#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vaccins antiviraux", "description": "Quels sont les facteurs de risque pour les infections virales ?\nLes antécédents médicaux influencent-ils la vaccination ?\nLes voyages augmentent-ils le risque d'infection ?\nLes personnes âgées ont-elles plus de risques ?\nLe mode de vie influence-t-il le risque d'infection ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Quality+Improvement#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection virale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests virologiques, des analyses sanguines et des symptômes cliniques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les vaccins antiviraux ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sérologiques et des cultures virales sont souvent utilisés pour évaluer l'immunité." } }, { "@type": "Question", "name": "Les symptômes indiquent-ils un besoin de vaccin ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fièvre ou la fatigue peuvent indiquer une infection nécessitant un vaccin." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité d'un vaccin ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par des études cliniques et des taux d'infection dans la population vaccinée." } }, { "@type": "Question", "name": "Les tests de dépistage sont-ils nécessaires avant vaccination ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests peuvent être recommandés pour certaines populations à risque avant la vaccination." } }, { "@type": "Question", "name": "Quels symptômes nécessitent un vaccin antiviral ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la toux, la fièvre ou des douleurs musculaires peuvent indiquer un besoin." } }, { "@type": "Question", "name": "Les effets secondaires des vaccins sont-ils fréquents ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires comme la douleur au site d'injection sont courants mais généralement légers." } }, { "@type": "Question", "name": "Comment distinguer une infection d'un effet secondaire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les infections présentent des symptômes persistants, tandis que les effets secondaires sont temporaires." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de vaccin ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon le type de vaccin et la réponse immunitaire individuelle." } }, { "@type": "Question", "name": "Les symptômes d'une infection virale sont-ils similaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreuses infections virales partagent des symptômes comme la fièvre et la fatigue." } }, { "@type": "Question", "name": "Comment les vaccins antiviraux préviennent-ils les infections ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Ils stimulent le système immunitaire à reconnaître et combattre les virus spécifiques." } }, { "@type": "Question", "name": "À quel âge doit-on commencer la vaccination antivirale ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'âge de vaccination dépend du vaccin, mais beaucoup commencent dès l'enfance." } }, { "@type": "Question", "name": "Les vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certains vaccins sont sûrs pendant la grossesse, mais il est essentiel de consulter un médecin." } }, { "@type": "Question", "name": "Les vaccins protègent-ils contre toutes les souches virales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccins ciblent des souches spécifiques, et des mises à jour peuvent être nécessaires." } }, { "@type": "Question", "name": "Quelle est l'importance de la vaccination de masse ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination de masse aide à atteindre l'immunité collective et à réduire la propagation des virus." } }, { "@type": "Question", "name": "Les vaccins antiviraux sont-ils des traitements ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccins préviennent les infections, tandis que les traitements ciblent les infections existantes." } }, { "@type": "Question", "name": "Quels traitements sont disponibles après infection ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des antiviraux comme l'oseltamivir peuvent être prescrits pour traiter certaines infections virales." } }, { "@type": "Question", "name": "Les vaccins peuvent-ils réduire la gravité des symptômes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccins peuvent atténuer la gravité des symptômes en cas d'infection post-vaccination." } }, { "@type": "Question", "name": "Les traitements sont-ils nécessaires après vaccination ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Pas nécessairement, mais des traitements peuvent être requis si une infection survient malgré la vaccination." } }, { "@type": "Question", "name": "Les vaccins antiviraux nécessitent-ils des traitements préventifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccins sont une mesure préventive, mais des traitements peuvent être nécessaires en cas d'exposition." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après vaccination ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rares incluent des réactions allergiques sévères ou des syndromes neurologiques." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Non, la plupart des complications sont rares et les bénéfices de la vaccination l'emportent sur les risques." } }, { "@type": "Question", "name": "Comment gérer les complications post-vaccinales ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Consulter un professionnel de santé pour évaluer et traiter les complications éventuelles." } }, { "@type": "Question", "name": "Les complications varient-elles selon le vaccin ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque vaccin peut avoir des profils de complications différents selon sa composition." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter l'immunité ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent temporairement affecter la réponse immunitaire, mais cela est rare." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les infections virales ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les maladies chroniques, et l'immunodépression." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils la vaccination ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de réactions allergiques ou de maladies peuvent influencer le choix du vaccin." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones à risque peut augmenter l'exposition à des virus spécifiques." } }, { "@type": "Question", "name": "Les personnes âgées ont-elles plus de risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles de développer des complications graves liées aux infections." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque d'infection ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain, incluant une bonne nutrition et de l'exercice, peut réduire le risque." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale

Validation scientifique effectuée le 18/02/2025

Contenu vérifié selon les dernières recommandations médicales

En savoir plus sur Dr Menir

Sous-catégories

36 au total
└─

Vaccins anti-adénovirus

Adenovirus Vaccines D062705 - D20.215.894.899.024
└─

Vaccins contre le SIDA

AIDS Vaccines D016915 - D20.215.894.899.050
└─

Vaccins contre la COVID-19

COVID-19 Vaccines D000086663 - D20.215.894.899.085
└─

Vaccins contre le cytomégalovirus

Cytomegalovirus Vaccines D022482 - D20.215.894.899.120
└─

Vaccins contre la dengue

Dengue Vaccines D053059 - D20.215.894.899.162
└─

Vaccins contre la maladie à virus Ebola

Ebola Vaccines D046129 - D20.215.894.899.205
└─

Vaccins contre les herpèsvirus

Herpesvirus Vaccines D022283 - D20.215.894.899.290
└─

Vaccins antigrippaux

Influenza Vaccines D007252 - D20.215.894.899.302
└─

Vaccins contre l'encéphalite japonaise

Japanese Encephalitis Vaccines D022321 - D20.215.894.899.320
└─

Vaccin contre la rougeole

Measles Vaccine D008458 - D20.215.894.899.404
└─

Vaccin antiourlien

Mumps Vaccine D009108 - D20.215.894.899.488
└─

Vaccins contre les papillomavirus

Papillomavirus Vaccines D053918 - D20.215.894.899.498
└─

Vaccins contre les virus para-influenza

Parainfluenza Vaccines D022241 - D20.215.894.899.500
└─

Vaccins antipoliomyélitiques

Poliovirus Vaccines D023321 - D20.215.894.899.623
└─

Vaccins contre la maladie d'Aujeszky

Pseudorabies Vaccines D022421 - D20.215.894.899.632
└─

Vaccins antirabiques

Rabies Vaccines D011819 - D20.215.894.899.700
└─

Vaccins contre les virus respiratoires syncytiaux

Respiratory Syncytial Virus Vaccines D022261 - D20.215.894.899.730
└─

Vaccins anti-rotavirus

Rotavirus Vaccines D022243 - D20.215.894.899.760
└─

Vaccin antirubéoleux

Rubella Vaccine D012411 - D20.215.894.899.779
└─

Vaccins contre le SIDA simien

SAIDS Vaccines D018449 - D20.215.894.899.790
└─

Vaccin antivariolique

Smallpox Vaccine D012900 - D20.215.894.899.859
└─

Vaccins contre les hépatites virales

Viral Hepatitis Vaccines D014761 - D20.215.894.899.955
└─

Vaccins contre le virus du Nil occidental

West Nile Virus Vaccines D053060 - D20.215.894.899.962
└─

Vaccin antiamaril

Yellow Fever Vaccine D022341 - D20.215.894.899.970
└─└─

Vaccin ChAdOx1 nCoV-19

ChAdOx1 nCoV-19 D000090985 - D20.215.894.899.085.063
└─└─

Ad26COVS1

Ad26COVS1 D000090984 - D20.215.894.899.085.125
└─└─

Vaccin contre la varicelle

Chickenpox Vaccine D019433 - D20.215.894.899.290.130
└─└─

Vaccins contre les virus herpès simplex

Herpes Simplex Virus Vaccines D022301 - D20.215.894.899.290.400
└─└─

Vaccins contre la maladie de Marek

Marek Disease Vaccines D022501 - D20.215.894.899.290.500
└─└─

Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 D000068857 - D20.215.894.899.498.500
└─└─

Vaccin antipoliomyélitique inactivé

Poliovirus Vaccine, Inactivated D011054 - D20.215.894.899.623.500
└─└─

Vaccin antipoliomyélitique oral

Poliovirus Vaccine, Oral D011055 - D20.215.894.899.623.750
└─└─

Vaccin contre la rougeole, les oreillons et la rubéole

Measles-Mumps-Rubella Vaccine D022542 - D20.215.894.899.779.500
└─└─

Vaccins anti-hépatite A

Hepatitis A Vaccines D022362 - D20.215.894.899.955.395
└─└─

Vaccins anti-hépatite B

Hepatitis B Vaccines D017325 - D20.215.894.899.955.400
└─└─└─

Vaccin contre le zona

Herpes Zoster Vaccine D053061 - D20.215.894.899.290.130.400

Auteurs principaux

Yukai Huang

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :

Xiao Guo

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :

Yuancheng Zhou

2 publications dans cette catégorie

Affiliations :
  • Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China.
Publications dans "Vaccins antiviraux" :

Dongying Liu

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :

Jingrui Mao

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :

Yongai Xiong

2 publications dans cette catégorie

Affiliations :
  • Department of Pharmaceutics, School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :

Youcai Deng

2 publications dans cette catégorie

Affiliations :
  • Department of Hematology, College of Pharmacy, Army Medical University (Third Military Medical University), Chongqing, China.
Publications dans "Vaccins antiviraux" :

Xinghong Gao

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
  • Provincial Department of Education, Key Laboratory of Infectious Disease & Bio-Safety, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :

Chit Laa Poh

2 publications dans cette catégorie

Affiliations :
  • Centre for Virus and Vaccine Research, Sunway University, Bandar Sunway, Malaysia.
Publications dans "Vaccins antiviraux" :

Lianpan Dai

2 publications dans cette catégorie

Affiliations :
  • CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. dailp@im.ac.cn.
Publications dans "Vaccins antiviraux" :

Zhou Xing

2 publications dans cette catégorie

Affiliations :
  • McMaster Immunology Research Centre and Department of Medicine, McMaster University, Hamilton, ON L8S 4K1, Canada. Electronic address: xingz@mcmaster.ca.
Publications dans "Vaccins antiviraux" :

Scott B Halstead

1 publication dans cette catégorie

Affiliations :
  • , Rockville, MD, USA. halsteads@erols.com.
Publications dans "Vaccins antiviraux" :

Naina McCann

1 publication dans cette catégorie

Affiliations :
  • Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: Naina.mccann@paediatrics.ox.ac.uk.
Publications dans "Vaccins antiviraux" :

Daniel O'Connor

1 publication dans cette catégorie

Affiliations :
  • Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :

Teresa Lambe

1 publication dans cette catégorie

Affiliations :
  • Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :

Andrew J Pollard

1 publication dans cette catégorie

Affiliations :
  • Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :

Antonio Lembo

1 publication dans cette catégorie

Affiliations :
  • Department of Chemical Sciences, University of Naples Federico II, Naples, Italy; GSK, Siena, Italy.
Publications dans "Vaccins antiviraux" :

Antonio Molinaro

1 publication dans cette catégorie

Affiliations :
  • Department of Chemical Sciences, University of Naples Federico II, Naples, Italy.
Publications dans "Vaccins antiviraux" :

Cristina De Castro

1 publication dans cette catégorie

Affiliations :
  • Department of Chemical Sciences, University of Naples Federico II, Naples, Italy. Electronic address: cristina.decastro@unina.it.
Publications dans "Vaccins antiviraux" :

Francesco Berti

1 publication dans cette catégorie

Affiliations :
  • GSK, Siena, Italy.
Publications dans "Vaccins antiviraux" :

Sources (10000 au total)

Mapping quality improvement education initiatives to Standards for QUality Improvement Reporting Excellence (SQUIRE) guidelines.

Aug 2023
DOI: 10.1111/jocn.16610 PMID: 36604856

To explore the rigour of nurse-led quality improvement projects involving education, training or continuing professional development, and examine evaluation frameworks contained within.... Healthcare organisations invest significantly in quality improvement in the pursuit of cost-effective, safe, evidence-based and person-centred care. Consequently, efforts to examine the success of inv... A qualitative document analysis of quality improvement projects located in a local health district repository was undertaken.... N = 3004 projects were screened against inclusion criteria, with n = 160 projects remaining for analysis. Projects were mapped to an adapted version of the Standards for QUality Improvement Reporting ... Of n = 60 completed projects assessed against four broad SQUIRE-EDU categories and relevant criteria, n = 36 were assessed not to have met any categories, n = 14 projects met one category, n = 8 proje... Scientific rigour should underpin all quality improvement efforts. We recommend that SQUIRE international consensus guidelines (full or abridged) should guide both the design and reporting of all loca... To be of value to the expansion of evidence-based practice, quality improvement platforms should be designed to reflect the structural logic, rigour and reporting recommendations being advocated in co...

Humans Quality Improvement Retrospective Studies Educational Status Delivery of Health Care +1 autres

Coaching quality improvement in primary care to improve hypertension control.

01 Jul 2022
DOI: 10.1097/JXX.0000000000000731 PMID: 35580278

Effective management of hypertension (HTN) is a priority in primary care, necessary to decrease the costs, morbidity, and mortality associated with cardiovascular disease. Strategies to support qualit... To address the high rate (>50%) of uncontrolled HTN in the state of Ohio, a statewide QI project was implemented in high-volume Medicaid practices, aimed at improving blood pressure control and addres... The Model for Improvement guided development of Plan-Do-Study-Act (PDSA) cycles facilitated by QI coaching and APRN collaboration to implement key components of HTN guidelines: accurate blood pressure... Interventions were implemented after PDSA cycles over 18 months in two practice sites to address HTN control. Linking multiple PDSA test cycles and review of data bimonthly allowed for reflection on t... The percentage of patients with controlled HTN, repeat blood pressure measurement, and timely follow-up improved in an urban primary care practice associated with an academic medical center and in a r... Primary care practices can benefit from the external support of coaching when implementing QI processes to make meaningful change. APRNs are key collaborators for expanding QI efforts in primary care....

Academic Medical Centers Humans Hypertension Mentoring Primary Health Care +1 autres

Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening.

01 11 2022
DOI: 10.1001/jamanetworkopen.2022.42354 PMID: 36383381

Cancer screening deficits during the first year of the COVID-19 pandemic were found to persist into 2021. Cancer-related deaths over the next decade are projected to increase if these deficits are not... To assess whether participation in a nationwide quality improvement (QI) collaborative, Return-to-Screening, was associated with restoration of cancer screening.... Accredited cancer programs electively enrolled in this QI study. Project-specific targets were established on the basis of differences in mean monthly screening test volumes (MTVs) between representat... Collaborative QI support included provision of a Return-to-Screening plan-do-study-act protocol, evidence-based screening interventions, QI education, programmatic coordination, and calculation of scr... The primary outcome was the proportion of QI projects reaching target MTV and counterfactual differences in the aggregate number of screening tests across time periods.... Of 859 cancer screening QI projects (452 for breast cancer, 134 for colorectal cancer, 244 for lung cancer, and 29 for cervical cancer) conducted by 786 accredited cancer programs, 676 projects (79%) ... In this QI study, participation in a national Return-to-Screening collaborative with a multifaceted QI intervention was associated with improvements in cancer screening. Future collaborative QI endeav...

Humans Quality Improvement Early Detection of Cancer Pandemics COVID-19 +2 autres